Skip to main content
NVDA+0.10%AAPL+0.49%GOOGL+1.69%MSFT-1.02%AMZN-0.37%TSM+0.34%SPCX+1.28%META+0.26%AVGO-0.40%TSLA+0.34%SKHY+2.39%MU+2.74%LLY-1.06%BRK-B+0.28%AMD+0.05%JPM-2.01%WMT+0.26%V-0.69%XOM-0.29%ASMLa+1.50%JNJ-1.56%INTC-0.35%0700.HK+5.02%MA-0.52%ABBV-0.29%1398.HK-0.53%CSCO-2.96%ORCL+2.41%BAC-0.83%CVX-0.38%COST-0.23%DELL-1.24%LRCX+0.60%CAT-0.88%KO+0.46%AMAT+0.64%AP2d+1.49%0005.HK-1.36%HSBA.L-0.40%PG+0.69%ARM+1.16%UNH-0.50%GE+0.20%3988.HK-0.66%MS-1.56%1816.HK-0.71%NFLX-1.56%0939.HK-0.20%0857.HK-0.84%HD+1.20%CADCHF-0.74%NZDCAD+0.67%USDTHB-0.60%EURCHF-0.51%USDCAD+0.50%CHFJPY+0.50%NZDMXN+0.49%GBPCHF-0.48%EURNZD-0.48%NZDJPY+0.42%GBPTRY+0.41%GBPNZD-0.40%AUDCHF-0.37%AUDCAD+0.36%GBPHKD+0.32%AUDNZD-0.31%EURZAR-0.29%GBPMXN-0.28%PLNJPY-0.28%EURUSD-0.28%CADJPY-0.28%GBPCAD+0.26%GBPZAR-0.26%USDCHF-0.26%GBPUSD-0.24%USDJPY+0.23%USDZAR-0.21%NZDSGD+0.20%EURNOK-0.19%EURSGD-0.19%USDMXN+0.19%EURCAD+0.19%USDPLN+0.18%AUDNOK-0.18%EURSEK-0.18%AUDSGD-0.17%NZDUSD+0.17%USDILS+0.16%GBPSGD-0.15%AUDUSD-0.13%EURAUD-0.13%EURHKD-0.12%USDTRY+0.11%USDNOK-0.11%USDSGD-0.11%GBPAUD-0.10%EURPLN+0.10%AUDJPY+0.09%USDSEK-0.09%EURCZK+0.09%USDDKK+0.08%EURJPY-0.06%NZDCHF-0.05%USDCOP-0.04%CHFSEK+0.04%EURGBP-0.03%USDHKD-0.02%CHFNOK+0.02%AUDDKK+0.02%CHFSGD+0.02%NOKJPY+0.02%USDCNH+0.01%EURCNH-0.01%SGDJPY+0.01%GBPJPY-0.01%EURDKK0.00%COCOA+3.02%XNGUSD+2.46%USOIL-1.70%UKOIL-1.31%HG1+1.02%COTTON-0.76%XPTUSD+0.66%W1+0.40%S1+0.33%GAGUSD-0.29%SUGAR+0.29%XAUUSD-0.28%BTCUSD-0.55%ETHUSD+0.95%USDTUSD-0.03%XRPUSD+3.80%SOLUSD-1.13%TRXUSDT-0.49%ZECUSDT+3.34%DOGEUSD+0.96%XMRUSDT+0.78%LINKUSD+0.60%XLMUSD-0.19%BCHUSDT+21.53%UNIUSD+1.02%LTCUSD+0.08%HBARUSDT+4.46%SUIUSD+1.75%TONUSD+18.31%TAOUSDT+2.26%AAVEUSD-1.18%DOTUSDT-0.49%ICPUSDT+0.62%ONDOUSDT-1.31%ARBUSDT-1.89%WLDUSDT+1.12%JUPUSDT-0.84%ATOMUSDT-2.46%INJUSDT+2.99%STXUSDT+0.91%FETUSDT+4.33%SEIUSDT+3.62%TIAUSDT+2.46%PYTHUSDT-0.42%IMXUSDT+0.52%WIFUSDT+4.61%GRTUSDT+3.15%OPUSDT+1.18%IOTAUSDT+0.02%FARTCOINUSDT-1.19%POLUSDT-3.34%AXSUSDT-0.73%EOSUSDT+1.50%DYDXUSDT+2.35%ORDIUSDT-0.68%GALAUSDT-0.15%NOTUSDT-2.28%RONINUSDT-0.79%NVDA+0.10%AAPL+0.49%GOOGL+1.69%MSFT-1.02%AMZN-0.37%TSM+0.34%SPCX+1.28%META+0.26%AVGO-0.40%TSLA+0.34%SKHY+2.39%MU+2.74%LLY-1.06%BRK-B+0.28%AMD+0.05%JPM-2.01%WMT+0.26%V-0.69%XOM-0.29%ASMLa+1.50%JNJ-1.56%INTC-0.35%0700.HK+5.02%MA-0.52%ABBV-0.29%1398.HK-0.53%CSCO-2.96%ORCL+2.41%BAC-0.83%CVX-0.38%COST-0.23%DELL-1.24%LRCX+0.60%CAT-0.88%KO+0.46%AMAT+0.64%AP2d+1.49%0005.HK-1.36%HSBA.L-0.40%PG+0.69%ARM+1.16%UNH-0.50%GE+0.20%3988.HK-0.66%MS-1.56%1816.HK-0.71%NFLX-1.56%0939.HK-0.20%0857.HK-0.84%HD+1.20%CADCHF-0.74%NZDCAD+0.67%USDTHB-0.60%EURCHF-0.51%USDCAD+0.50%CHFJPY+0.50%NZDMXN+0.49%GBPCHF-0.48%EURNZD-0.48%NZDJPY+0.42%GBPTRY+0.41%GBPNZD-0.40%AUDCHF-0.37%AUDCAD+0.36%GBPHKD+0.32%AUDNZD-0.31%EURZAR-0.29%GBPMXN-0.28%PLNJPY-0.28%EURUSD-0.28%CADJPY-0.28%GBPCAD+0.26%GBPZAR-0.26%USDCHF-0.26%GBPUSD-0.24%USDJPY+0.23%USDZAR-0.21%NZDSGD+0.20%EURNOK-0.19%EURSGD-0.19%USDMXN+0.19%EURCAD+0.19%USDPLN+0.18%AUDNOK-0.18%EURSEK-0.18%AUDSGD-0.17%NZDUSD+0.17%USDILS+0.16%GBPSGD-0.15%AUDUSD-0.13%EURAUD-0.13%EURHKD-0.12%USDTRY+0.11%USDNOK-0.11%USDSGD-0.11%GBPAUD-0.10%EURPLN+0.10%AUDJPY+0.09%USDSEK-0.09%EURCZK+0.09%USDDKK+0.08%EURJPY-0.06%NZDCHF-0.05%USDCOP-0.04%CHFSEK+0.04%EURGBP-0.03%USDHKD-0.02%CHFNOK+0.02%AUDDKK+0.02%CHFSGD+0.02%NOKJPY+0.02%USDCNH+0.01%EURCNH-0.01%SGDJPY+0.01%GBPJPY-0.01%EURDKK0.00%COCOA+3.02%XNGUSD+2.46%USOIL-1.70%UKOIL-1.31%HG1+1.02%COTTON-0.76%XPTUSD+0.66%W1+0.40%S1+0.33%GAGUSD-0.29%SUGAR+0.29%XAUUSD-0.28%BTCUSD-0.55%ETHUSD+0.95%USDTUSD-0.03%XRPUSD+3.80%SOLUSD-1.13%TRXUSDT-0.49%ZECUSDT+3.34%DOGEUSD+0.96%XMRUSDT+0.78%LINKUSD+0.60%XLMUSD-0.19%BCHUSDT+21.53%UNIUSD+1.02%LTCUSD+0.08%HBARUSDT+4.46%SUIUSD+1.75%TONUSD+18.31%TAOUSDT+2.26%AAVEUSD-1.18%DOTUSDT-0.49%ICPUSDT+0.62%ONDOUSDT-1.31%ARBUSDT-1.89%WLDUSDT+1.12%JUPUSDT-0.84%ATOMUSDT-2.46%INJUSDT+2.99%STXUSDT+0.91%FETUSDT+4.33%SEIUSDT+3.62%TIAUSDT+2.46%PYTHUSDT-0.42%IMXUSDT+0.52%WIFUSDT+4.61%GRTUSDT+3.15%OPUSDT+1.18%IOTAUSDT+0.02%FARTCOINUSDT-1.19%POLUSDT-3.34%AXSUSDT-0.73%EOSUSDT+1.50%DYDXUSDT+2.35%ORDIUSDT-0.68%GALAUSDT-0.15%NOTUSDT-2.28%RONINUSDT-0.79%
JT

Janux Therapeutics, Inc. (JANX)

NASDAQ • Healthcare

$17.01
+$0.42 (+2.5%)
Market open

Last close at September 21, 2026 at 20:00 UTC

Open$16.86
Previous Close$17.01
Day Range$16.53 - $17.14
Avg. Volume (3M)1M
Market Cap$1B
52 Week Range
$12.12$35.34
Next EarningsIn 44 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$10.2M100%
Gross Profitminus cost of goods$10.2M100%

Fundamentals & Financials

Revenue (TTM)
$31.8M
Net Income (TTM)
-$102.5M
EPS (TTM)
-$1.64
ROA (TTM)
-10.18%
Current Ratio
16.35

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+21.5%Q1 2026-$0.51
+25.0%Q2 2026-$0.39
-39.3%Q3 2026-$0.35
Next

Nov 5

in 44 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Janux Therapeutics, Inc.

Janux Therapeutics, Inc. is a NASDAQ-listed biotechnology company developing cancer therapies, with $10.0 million of revenue in FY2025. The company centers its work on its proprietary Tumor Activated T Cell Engager, or TRACTr, platform, which is designed to activate the body's T cells against tumors, and it operates from San Diego, California.

Name
Janux Therapeutics, Inc.
CEO
David Alan Campbell
Website
www.januxrx.com
Industry
Healthcare
Year Founded
2017
Employees
113

Today's Snapshot

AI-generated

JANX ended yesterday 2.5% up at 17.01.

Trading Volume

Below 10d avg (1.0M)

701.8K

vs S&P 500 Today

Outperforming Market

+1.04%

Updated: September 22, 2026 at 12:30 UTC

Technical Indicators

2 Buy1 Neutral5 Sell
JANX exhibits short-term weakness with the price below its ten- and twenty-period averages while remaining above the longer-term 200-day level, which points to near-term pressure against a longer-term base. Momentum and MACD readings are negative and stochastic is beginning to show limited support, yet OBV is heavily negative, signaling distribution, and ADX indicates only a modest trend. ATR is moderate, so volatility is not extreme. Taken together, these factors explain the sell bias despite mixed longer-term averages. Technical takeaway: Sell — short- and medium-term weakness contrasts with longer-term support, with heavy selling pressure on volume.
All signals
  • EMA (5 indicators)$16.50 - $17.55
    Sell
  • RSI (14)46.11
    Neutral
  • Stochastic %K (14, 3, 3)18.27
    Buy
  • MACD Level (12, 26)-0.09
    Sell

Peers & Related Assets

CLDXCelldex Therapeutics, Inc.
$37.89-0.9%
VERAVera Therapeutics, Inc.
$34.25+0.7%
HRMYHarmony Biosciences Holdings, Inc.
$42.1+0.2%
IMNMImmunome, Inc.
$25.07+4.6%
BHVNBiohaven Ltd.
$14.22+4.4%
NUVBNuvation Bio Inc.
$6.07+3.8%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.